Literature DB >> 11828052

Montelukast and Churg-Strauss syndrome.

R Solans1, J A Bosch, A Selva, R Orriols, M Vilardell.   

Abstract

Several cases of eosinophilic conditions including Churg-Strauss syndrome (CSS) have recently been reported in asthmatic patients being treated with antileukotriene receptor antagonists. One patient with CSS who experienced a clinical relapse after treatment with montelukast and two asthmatic patients who developed CSS while receiving montelukast treatment are described. In one case reduction in the dose of oral steroid preceded the onset of CSS. To our knowledge, no case of CSS relapse has previously been reported in association with leukotriene antagonists.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11828052      PMCID: PMC1746257          DOI: 10.1136/thorax.57.2.183

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  8 in total

1.  Wegener's Granulomatosis after Treatment with Montelukast in a Patient not Receiving Systemic Corticosteroid Treatment.

Authors:  Aliye Candan Ogus; Aykut Cilli; Tulay Ozdemir; Gulay Ozbilim
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

Review 2.  Benefit-risk assessment of antileukotrienes in the management of asthma.

Authors:  Luis García-Marcos; Antje Schuster; Eduardo G Pérez-Yarza
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Montelukast-associated Churg-Strauss vasculitis: another associated report.

Authors:  Jonathan G Black; James R Bonner; Dennis Boulware; Aleodor A Andea
Journal:  Ann Allergy Asthma Immunol       Date:  2009-04       Impact factor: 6.347

4.  Churg-Strauss syndrome (CSS) in a patient receiving pranlukast.

Authors:  Shigeto Kobayashi; Shyugo Ishizuka; Naoto Tamura; Makiyo Takaya; Kazuhiko Kaneda; Hiroshi Hashimoto
Journal:  Clin Rheumatol       Date:  2003-11-04       Impact factor: 2.980

5.  The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction?

Authors:  Deanna L McDanel; Barbara A Muller
Journal:  Ther Clin Risk Manag       Date:  2005-06       Impact factor: 2.423

Review 6.  Is Leukotriene Receptor Antagonist the Direct Cause of Churg-Strauss Syndrome in Asthmatic Patients?

Authors:  Salomi Paul; Shreyas Yakkali; Sneha Teresa Selvin; Sonu Thomas; Viktoriya Bikeyeva; Ahmed Abdullah; Aleksandra Radivojevic; Anas A Abu Jad; Anvesh Ravanavena; Chetna Ravindra; Emmanuelar O Igweonu-Nwakile; Safina Ali; Pousette Hamid
Journal:  Cureus       Date:  2022-08-14

7.  Churg-strauss syndrome in the pediatric age group.

Authors:  Yehia El-Gamal
Journal:  World Allergy Organ J       Date:  2008-02       Impact factor: 4.084

8.  Leukotriene Antagonists in Dermatology.

Authors:  Aditya Kumar Bubna
Journal:  Indian J Dermatol       Date:  2021 Sep-Oct       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.